A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients

Exclusion Criteria

• •Co-existing Condition:
• •Patients with the following symptoms and conditions are excluded:
• •Symptoms of pancreatitis or peripheral neuropathy of grade 2 or worse.
• •Requirement for acute therapy for any active AIDS-defining opportunistic infection or systemic chemotherapy for malignancy.
• •Stage 2 or worse (moderate) AIDS Dementia Complex.
• •Other disorders or conditions for which the study drugs are contraindicated or that may prevent adequate compliance with study therapy.
• •Concurrent Medication:
• •Excluded:
• •Acute therapy for active AIDS-defining opportunistic infection.
• •Systemic chemotherapy for malignancy.
• •Antiretroviral therapy other than that provided by this study.
• •Patients with the following prior conditions are excluded:
• •History of pancreatitis or peripheral neuropathy of grade 2 or worse.
• •History of intolerance to the study drugs at entry doses and/or frequencies.
• •History of phenylketonuria.